| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Matti Bock Guldager, Adriano Maia Chaves Filho, Caroline Biojone, Sâmia Joc. Therapeutic potential of cannabidiol in depression. International review of neurobiology. vol 177. 2024-07-19. PMID:39029987. |
therapeutic potential of cannabidiol in depression. |
2024-07-19 |
2024-07-22 |
human |
| John Mark Wiginton, K Rivet Amico, Lisa Hightow-Weidman, Patrick Sullivan, Keith J Horvat. Syndemic Psychosocial Conditions among Youth Living with HIV: a Latent Class Analysis. AIDS and behavior. 2024-07-17. PMID:39017755. |
using baseline data from 208 ylwh enrolled in an hiv treatment adherence intervention, we performed latent class analysis on dichotomized responses to 9 psychosocial indicators (enacted hiv stigma; clinical depression and anxiety; alcohol, marijuana, and illicit drug misuse; food and housing insecurity; legal history). |
2024-07-17 |
2024-07-19 |
human |
| Alexander L Wallace, Marilyn A Huestis, Ryan M Sullivan, Natasha E Wad. Amygdala Volume and Depression Symptoms in Young Adolescents Who Use Cannabis. Behavioural brain research. 2024-07-15. PMID:39009188. |
amygdala volume and depression symptoms in young adolescents who use cannabis. |
2024-07-15 |
2024-07-18 |
Not clear |
| R Nathan Pipitone, Benjamin Banai, Jessica Walters, Tyler Dautrich, Kelly Schuller, Martha Rosentha. Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users. Cannabis (Albuquerque, N.M.). vol 7. issue 2. 2024-07-08. PMID:38975597. |
the present study uses smartphone technology to assess self-reported experiences of florida cannabis users to understand how cannabis may impact anxiety and depression symptomatology. |
2024-07-08 |
2024-07-11 |
Not clear |
| C Poyatos-Pedrosa, G Bernabe-Valero, L Pelacho-Ríos, I Iborra-Marmolej. Cannabis and anhedonia: A systematic review. Psychiatry research. vol 339. 2024-07-03. PMID:38959579. |
experimental animal studies focused on exploring the association between cannabidiol (cbd) and anhedonia, while human studies primarily employed observational research, examining various forms of anhedonia in individuals with or without mental disorders such as depression or psychosis. |
2024-07-03 |
2024-07-10 |
human |
| Jozsef Halle. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931356. |
herbal cannabis and depression: a review of findings published over the last three years. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jozsef Halle. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931356. |
in most cross-sectional studies, depression was higher in those who consumed cannabis than in those who did not. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jozsef Halle. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931356. |
an increase in cannabis consumption was typically followed by an increase in depression, whereas withdrawal from cannabis ameliorated depression in most cases. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jozsef Halle. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931356. |
although medical cannabis reduced depression in most studies, none of these were placebo-controlled. |
2024-06-27 |
2024-06-29 |
Not clear |
| Jozsef Halle. Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931356. |
in clinical studies published in the same period, the placebo also ameliorated depression and, in addition, the average effect size of the placebo was larger than the average effect size of medical cannabis. |
2024-06-27 |
2024-06-29 |
Not clear |
| Rebecca K Denson, Julia Brooks, Graziano Pinna, Natania A Cran. Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research. Adolescent psychiatry (Hilversum, Netherlands). vol 13. issue 3. 2024-06-26. PMID:38919887. |
adolescents and young adults may use cannabidiol (cbd) products in an attempt to reduce depression and anxiety symptoms, despite little research examining this use. |
2024-06-26 |
2024-06-29 |
Not clear |
| Ari Brouwer, Robin L Carhart-Harris, Charles L Raiso. Psychotomimetic compensation versus sensitization. Pharmacology research & perspectives. vol 12. issue 4. 2024-06-26. PMID:38923845. |
it is a paradox that psychotomimetic drugs can relieve symptoms that increase risk of and cooccur with psychosis, such as attention and motivational deficits (e.g., amphetamines), pain (e.g., cannabis) and symptoms of depression (e.g., psychedelics, dissociatives). |
2024-06-26 |
2024-06-29 |
Not clear |
| Isaac C Rhew, Sabrina Oesterle, Margaret R Kuklinski, Katarina Guttmannova, Jennifer M Cadiga. The longitudinal association of cumulative depression with cannabis use disorder among young adults. Journal of studies on alcohol and drugs. 2024-06-20. PMID:38900055. |
the longitudinal association of cumulative depression with cannabis use disorder among young adults. |
2024-06-20 |
2024-06-22 |
Not clear |
| Shivani Mathur Gaiha, Maggie Wang, Mike Baiocchi, Bonnie Halpern-Felshe. Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. Addictive behaviors. vol 156. 2024-06-05. PMID:38838604. |
depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. |
2024-06-05 |
2024-06-08 |
Not clear |
| Shivani Mathur Gaiha, Maggie Wang, Mike Baiocchi, Bonnie Halpern-Felshe. Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. Addictive behaviors. vol 156. 2024-06-05. PMID:38838604. |
few studies examine the relationship between depression and use of specific tobacco and/or cannabis products among adolescents, young adults, and adults. |
2024-06-05 |
2024-06-08 |
Not clear |
| Shivani Mathur Gaiha, Maggie Wang, Mike Baiocchi, Bonnie Halpern-Felshe. Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. Addictive behaviors. vol 156. 2024-06-05. PMID:38838604. |
we determined whether the odds of depression are greater among those who used specific tobacco and/or cannabis products and among co-users of tobacco and cannabis. |
2024-06-05 |
2024-06-08 |
Not clear |
| Jafar Bakhshaie, James D Doorley, Nathaniel R Choukas, Nathan S Fishbein, Victoria A Grunberg, Ana-Maria Vrancean. Cannabis Co-Use Among Black Individuals with Chronic Pain Who Use Opioids: Associations with Other Substance Use and Pain Related Outcomes. Journal of health care for the poor and underserved. vol 35. issue 2. 2024-06-03. PMID:38828582. |
results compared with opioid use alone, opioid and cannabis co-use was associated with elevated anxiety and depression symptoms, opioid dependence, and risky substance use, but not pain. |
2024-06-03 |
2024-06-05 |
Not clear |
| Klara Mareckova, Radek Marecek, Lenka Andryskova, Milan Brazdil, Yuliya S Nikolov. Prenatal exposure to alcohol and its impact on reward processing and substance use in adulthood. Translational psychiatry. vol 14. issue 1. 2024-05-28. PMID:38806472. |
moreover, mid-pregnancy but not pre-conception exposure to alcohol was associated with greater cannabis use in young adulthood and these effects were independent of maternal education and maternal depression during pregnancy. |
2024-05-28 |
2024-06-02 |
human |
| Shulu Hu, Anqi Lin, Peng Luo, Jian Zhan. Correspondence to "Which came first, the cannabis or the depression?" Preventive medicine reports. vol 42. 2024-05-06. PMID:38707248. |
correspondence to "which came first, the cannabis or the depression?" |
2024-05-06 |
2024-05-08 |
Not clear |
| Lane G Chen, Justin D Tubbs, Zipeng Liu, Thuan-Quoc Thach, Pak C Sha. Mendelian randomization: causal inference leveraging genetic data. Psychological medicine. 2024-04-19. PMID:38639006. |
we showcase the practical use of mr in psychiatry through three illustrative examples - the connection between cannabis use and psychosis, the link between intelligence and schizophrenia, and the search for modifiable risk factors for depression. |
2024-04-19 |
2024-04-21 |
human |